Modeling phenotypes of malignant gliomas

被引:15
|
作者
Sampetrean, Oltea [1 ]
Saya, Hideyuki [1 ]
机构
[1] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Keio, Japan
关键词
experimental model; genetically engineered mouse model; glioma cell of origin; glioma invasion; malignant glioma; GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELL; MOSAIC ANALYSIS; DOUBLE MARKERS; MOUSE MODELS; BRAIN-TUMORS; GLIOBLASTOMA; ACTIVATION; MIGRATION; INVASION;
D O I
10.1111/cas.13351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant gliomas are primary tumors of the central nervous system characterized by diffuse infiltration into the brain and a high recurrence rate. Advances in comprehensive genomic studies have provided unprecedented insight into the genetic and molecular heterogeneity of these tumors and refined our understanding of their evolution from low to high grade. However, similar levels of phenotypic characterization are indispensable to understanding the complexity of malignant gliomas. Experimental glioma models have also achieved great progress in recent years. Advances in transgenic technologies and cell culture have allowed the establishment of mouse models that mirror the human disease with increasing fidelity and which support single-cell resolution for phenotypic analyses. Here we review the major types of preclinical glioma models, with an emphasis on how recent developments in experimental modeling have shed new light on two fundamental aspects of glioma phenotype, their cell of origin and their invasive potential.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 50 条
  • [41] Combination of Cyclophosphamide and Carboplatin in Recurrent Malignant Gliomas
    Demirci, Umut
    Buyukberber, Suleyman
    Ozdemir, Nuriye
    Coskun, Ugur
    Karaca, Halit
    Akmansu, Muge
    Yaman, Emel
    Baykara, Meltem
    Yamac, Deniz
    Uner, Aytug
    Benekli, Mustafa
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (03): : 178 - 183
  • [42] Fusion Genes Altered in Adult Malignant Gliomas
    You, Gan
    Fan, Xing
    Hu, Huimin
    Jiang, Tao
    Chen, Clark C.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [43] Astrocyte elevated gene-1 as a novel therapeutic target in malignant gliomas and its interactions with oncogenes and tumor suppressor genes
    Osama, Mahmoud
    Mostafa, Mostafa Nasr
    Alvi, Mohammed Ali
    BRAIN RESEARCH, 2020, 1747
  • [44] Vascular endothelial growth factor inhibitors in malignant gliomas
    Brastianos, Priscilla K.
    Batchelor, Tracy T.
    TARGETED ONCOLOGY, 2010, 5 (03) : 167 - 174
  • [45] Safety of bevacizumab in patients with malignant gliomas: a systematic review
    Simonetti, G.
    Trevisan, E.
    Silvani, A.
    Gaviani, P.
    Botturi, A.
    Lamperti, E.
    Beecher, D.
    Bertero, L.
    Bosa, C.
    Salmaggi, A.
    NEUROLOGICAL SCIENCES, 2014, 35 (01) : 83 - 89
  • [46] Application of Targeted Therapy to Malignant Gliomas and Response to Treatment
    Lee, Eudocia Q.
    Norden, Andrew D.
    Drappatz, Jan
    Wen, Patrick Y.
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2013, 8 (01) : 14 - 24
  • [47] Temozolomide in malignant gliomas: current use and future targets
    Villano, J. Lee
    Seery, Tara E.
    Bressler, Linda R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 647 - 655
  • [48] Temozolomide in malignant gliomas: current use and future targets
    J. Lee Villano
    Tara E. Seery
    Linda R. Bressler
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 647 - 655
  • [49] Tumor Treating Fields in the Management of Patients with Malignant Gliomas
    Ghiaseddin, Ashley P.
    Shin, David
    Melnick, Kaitlyn
    Tran, David D.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (09)
  • [50] Vascular endothelial growth factor inhibitors in malignant gliomas
    Priscilla K. Brastianos
    Tracy T. Batchelor
    Targeted Oncology, 2010, 5 : 167 - 174